NCT07772934
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07772934
Title VBC117First-in-Human Trial of VBC117 in Participants With Advanced Malignant Solid Tumors
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors VelaVigo Bio Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Macquarie University Randwick New South Wales 2031 Australia Details
Scientia Clinical Research Randwick New South Wales 2031 Australia Details
Cancer Care Wollongong Wollongong New South Wales 2500 Australia Details
Peninsula and South Eastern Haematology and Oncology Group Frankston Victoria 3199 Australia Details
The Second Affiliated Hospital of Zhejiang University School of Medicine Zhejiang Hangzhou 310009 China Details
The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan 450052 China Details
Hunan Cancer Hospital Changsha Hunan 410013 China Details
The Second Affiliated Hospital of Nanchang University Nanchang Jiangxi 330006 China Details
Liaoning Cancer Hospital & Institute Shengyang Liaoning 110042 China Details
Shanghai East Hospital Shanghai Shanghai Municipality 200120 China Details
Shanghai GoBroad Cancer Hospital Shanghai Shanghai Municipality 200120 China Details
First Hospital of Shanxi Medical University Taiyuan Shanxi 030001 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field